Back to Search
Start Over
Evaluation of Hepatitis C Treatment Outcomes Among Patients Enrolled in Outpatient Parenteral Antibiotic Therapy-Boston, Massachusetts, 2016-2021.
- Source :
-
Open forum infectious diseases [Open Forum Infect Dis] 2023 Jul 05; Vol. 10 (7), pp. ofad342. Date of Electronic Publication: 2023 Jul 05 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- In our Boston-based outpatient parenteral antibiotic therapy (OPAT) program between 2016 and 2021, we found that a low proportion of patients with active hepatitis C virus (HCV) were prescribed HCV treatment by their OPAT provider and few achieved sustained virologic response. Clinicians should consider concurrent HCV treatment during OPAT.<br />Competing Interests: Potential conflicts of interest. A. Y. K. serves on the Data Safety Monitoring Board for Kintor Pharmaceuticals, Inc. S. B. N. and K. L. A. are coauthors of the “Outpatient Parenteral Antimicrobial Therapy” article for UpToDate, Inc. All other authors report no potential conflicts.<br /> (© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
Details
- Language :
- English
- ISSN :
- 2328-8957
- Volume :
- 10
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Open forum infectious diseases
- Publication Type :
- Academic Journal
- Accession number :
- 37496604
- Full Text :
- https://doi.org/10.1093/ofid/ofad342